Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
ID: 350876Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350876

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-048.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovative research in the implementation of genomic information in clinical care across diverse populations. This grant supports small research projects that can be conducted in a short timeframe with limited resources, focusing on enhancing the generalizability of findings and improving health outcomes while addressing barriers to the adoption of genomic medicine. Eligible applicants include various educational and nonprofit institutions, with a maximum budget of $50,000 in direct costs per year and a project duration of up to two years. Interested parties should submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HG-23-048-Full-Announcement.html
    RFA-HG-23-048.html
    The National Human Genome Research Institute (NHGRI) is soliciting proposals for the "Advancing Genomic Medicine Research" funding opportunity under the R03 Small Grant Program. Aimed at enhancing the implementation of genomic information in clinical care across diverse populations, the initiative seeks to stimulate innovative research on genomic medicine without clinical trials. Proposals should focus on the generalizability of findings beyond specific diseases, facilitating the integration of genomic data, improving health outcomes, and addressing barriers in adoption. Key elements include eligibility for various educational and nonprofit institutions, a maximum budget of $50,000 in direct costs per year, and a total project duration of up to two years. NHGRI encourages applications including previously underrepresented populations in genomic research, and emphasizes the need for stakeholder engagement and robust data sharing as per NIH policies. All applications must adhere strictly to submission guidelines, with deadlines aligned to 5:00 PM local time. Applications will be evaluated on scientific merit, innovation, significance, and the potential for generalizable impact on the field of genomic medicine.
    Similar Opportunities
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), has announced a funding opportunity for Small Research Grants (R03) aimed at analyzing existing genomic data related to dental, oral, and craniofacial health. This initiative encourages projects that utilize publicly available genomic data and advanced methodologies, focusing on oral health disparities and biological pathways to identify intervention targets. The grant supports projects with budgets up to $200,000 over two years, with applications due by May 7, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for a pilot program focused on Population Genomic Screening in Primary Care, designated as RFA-HG-24-021. This initiative aims to implement and evaluate screening for common genomic conditions, particularly targeting diverse populations and addressing health disparities, with a goal of enrolling approximately 5,000 patients per Clinical Group. The program emphasizes the importance of community engagement, establishing screening protocols, and ensuring follow-up care, while collaborating with a Coordinating Center and a Sequencing Center to integrate genomic screening into primary care settings. The total funding available is approximately $3.85 million, distributed across 4-5 awards over five years, with applications due by December 2, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for "Investigator Initiated Research in Computational Genomics and Data Science" (R01 Clinical Trial Not Allowed) aimed at advancing research in computational genomics, data science, and bioinformatics with applications to human health and disease. This initiative encourages innovative research efforts that enhance analytical methodologies, develop software tools, and improve genomic data management, with a focus on creating scalable solutions for increasingly large datasets. Eligible applicants include a diverse range of organizations such as higher education institutions, non-profits, and for-profit entities, with no cost-sharing requirement and a maximum budget of $500,000 in direct costs for projects not exceeding five years. Interested applicants should submit their proposals by January 7, 2025, and can direct inquiries to grantsinfo@nih.gov for further assistance.
    ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the opportunity titled "ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)" to establish Expert Panels focused on the clinical relevance of genetic variants. The primary objective of this initiative is to develop a comprehensive knowledge base that enhances the interpretation of genes and genomic variants associated with high-priority diseases, utilizing established tools and resources from the Clinical Genomics Resource (ClinGen) and ClinVar. This funding is crucial for advancing genomic research and improving clinical outcomes through precision medicine, with a maximum award ceiling of $220,000 per year for a grant period of up to three years. Interested applicants must submit their proposals by May 25, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NHGRI Short Courses for Genomics-Related Research Education" (R25), aimed at enhancing research education in genomics. This initiative supports the development of advanced short courses focused on skills development in genome sciences, genomic medicine, and the ethical, legal, and social implications of genomics, targeting both emerging and established researchers. Funded projects may receive up to $150,000 annually for a maximum duration of five years, with applications due by January 25, 2025. Interested applicants can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov or through the provided link to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-095.html.
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03), aimed at funding small-scale research projects that investigate the ethical, legal, and social dimensions of human genetics and genomics. This funding opportunity encourages innovative research that addresses the complexities and emerging questions associated with genomic advancements, particularly focusing on diverse populations and potential inequities in access and benefits. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government agencies, with funding of up to $50,000 available per year for a maximum of two years. Applications will be accepted starting January 19, 2024, with various submission deadlines through 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.